News

The company said that it will begin sales and marketing activities in the US, Europe and Australia. Pearl Fractional, with its proprietary 2,790nm wavelength, is the company’s solution

Mr Dugan joins Smith & Nephew from SonoSite, where he has served as the senior vice president of global marketing and US sales for the last three years.

Mr Smith, who brings more than 25 years of experience in leading global sales and marketing organizations for healthcare companies, also serves on Allocade’s board of directors. Prior

Previously, Barr has filed an abbreviated new drug application (ANDA) with the FDA for Janssen’s Razadyne (galantamine hydrobromide), 4mg, 8mg and 12mg tablets. Following receipt of notification from

The new system to be installed at Duke University will provide magnetic resonance imaging (MRI) monitoring of cancer treatments in progress as delivered by a BSD Medical system.

Dr Collen will remain chairman of ThromboGenics’s board of directors. This new structure is said to ensure the continuity of ThromboGenics’s senior management. Prior to joining ThromboGenics, Dr

Dave Wentz, CEO of Usana, said: “Entering the Philippines broadens Usana’s international reach and we are excited to offer many of our associate leaders an opportunity to expand

Ms Reinhard previous roles include serving as principal/consultant with dR3 recruiting, resources, results and director of human resources, training, facilities with Spectragraphics/SMS Technologies. Ms Reinhard will be focused

Mr Mason was also recently appointed to the newly created position of group president of North America at Orthofix, and will continue in that role. Mr Mason was